Cargando…

Risk of omicron infection for high-risk older adults in long-term care facilities

Detalles Bibliográficos
Autores principales:	Pallett, Scott J C, Heskin, Joseph, Keating, Fergus, Mazzella, Andrea, O'Shea, Matthew K, Moore, Luke S P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023164/ https://www.ncbi.nlm.nih.gov/pubmed/36940702 http://dx.doi.org/10.1016/S1473-3099(23)00179-2

Ejemplares similares

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022)

Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022)

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation
por: Pallett, Scott J. C., et al.
Publicado: (2023)

Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities
por: Breznik, Jessica A., et al.
Publicado: (2023)

COVID-19 Infection Risk Among Hemodialysis Patients in Long-term Care Facilities
por: Liu, Christine K., et al.
Publicado: (2020)

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
por: Antonelli, Michela, et al.
Publicado: (2022)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021)

Omicron with threatened antagonistic consequences and are convoyed by new fangled risks – Correspondence
por: Mukerjee, Nobendu, et al.
Publicado: (2022)

Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals.
por: Heskin, Joseph, et al.
Publicado: (2021)

Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose
por: Zhang, Yuemiao, et al.
Publicado: (2023)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
por: Hoxha, Ana, et al.
Publicado: (2021)

Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England
por: Krutikov, Maria, et al.
Publicado: (2021)

Effects of Vaccination and Previous Infection on Omicron Infections in Children
por: Lin, Dan-Yu, et al.
Publicado: (2022)

Effectiveness of Bivalent Boosters against Severe Omicron Infection
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Impact and risk factors of sepsis on long-term outcomes after spontaneous intracerebral hemorrhage
por: Lin, Jie, et al.
Publicado: (2022)

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel
por: Muhsen, Khitam, et al.
Publicado: (2021)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Functional dependence in daily living activities and frailty in patients older than 65 years admitted for COVID-19 with the Omicron variant
por: Rodríguez-Santonja, L., et al.
Publicado: (2023)

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
por: Accorsi, Emma K., et al.
Publicado: (2022)

Long-term effects on survivors with COVID-19
por: Yang, Chengliang, et al.
Publicado: (2021)

Omicron: a challenge to hybrid immunity – correspondence
por: Niranjan, Ankush K., et al.
Publicado: (2023)

Three-dose vaccination elicits neutralising antibodies against omicron
por: Wu, Mary, et al.
Publicado: (2022)

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
por: Carr, Edward J, et al.
Publicado: (2022)

Letter in response to ‘Students’ age and parental level of education influence COVID-19 vaccination hesitancy’
por: Sakatsume, Risako, et al.
Publicado: (2022)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

Omicron: A new face of COVID‐19 pandemic
por: Khan, Amjad, et al.
Publicado: (2022)

Reduced sensitivity of antibody tests after omicron infection
por: Rössler, Annika, et al.
Publicado: (2023)

Finite neutralisation breadth of omicron after repeated vaccination
por: Zhu, Yufang, et al.
Publicado: (2022)

CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival
por: Szuber, Natasha, et al.
Publicado: (2018)

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
por: Fendler, Annika, et al.
Publicado: (2022)

Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
por: Solera, Javier T, et al.
Publicado: (2023)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6djb3455f69cko8if9v313m93